Harrison & Co Wealth Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$756K Buy
21,512
+4,399
+26% +$147K 0.73% 55
2022
Q3
$504K Sell
17,113
-954
-5% -$36.2K 0.53% 65
2022
Q2
$983K Buy
18,067
+310
+2% +$17.1K 0.93% 35
2022
Q1
$967K Sell
17,757
-765
-4% -$41.6K 0.85% 42
2021
Q4
$1.02M Buy
+18,522
New +$963K 0.86% 40

Other funds holding GSK

Harrison & Co Wealth Management's GSK Position: Q4 2022 in Review

Harrison & Co Wealth Management increased its GSK (GSK) stake by 26% in Q4 2022, buying an estimated $147K and bringing the position to 21,512 shares worth $756K. The position accounts for 0.73% of the portfolio, ranked #55.

Harrison & Co Wealth Management first reported a position in GSK in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.02M in Q4 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Harrison & Co Wealth Management held 21,512 shares of GSK worth $756K as of Q4 2022.
  • Harrison & Co Wealth Management bought 4,399 GSK shares in Q4 2022, an estimated $147K.
  • GSK made up 0.73% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #55 holding.
  • Harrison & Co Wealth Management first reported a position in GSK in Q4 2021 and has held it in 5 quarters since.
  • Harrison & Co Wealth Management's GSK position peaked at $1.02M in Q4 2021.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.